source
- Vistagen’s anxiety nasal spray fails to outperform placebo in Phase 2 studyVistagen reported results of its Phase 2 trial of the investigational nasal spray fasedienol for social anxiety disorder. The study enrolled 61 patients who were randomly assigned to receive a sin…
- Senior staff purchase company shares, filing 16/2026 shows insider buyingThe company released a corporate announcement stating that several senior employees have bought shares of the firm. The filing, identified as 16/2026, does not provide details on the number of sha…